44 episodes

Conversations about Life Science, Science, Business, M&A, Technology, Pharma, and Philosophy. Do you want to stay updated? Join the LSG2G Community: https://lsg2g.substack.com/

Beginner's Mind Christian Soschner

    • Business

Conversations about Life Science, Science, Business, M&A, Technology, Pharma, and Philosophy. Do you want to stay updated? Join the LSG2G Community: https://lsg2g.substack.com/

    #44: Tero Weckroth - Private and Public Investments - Similarities and Differences from the Crowdfunding and Angel Perspective

    #44: Tero Weckroth - Private and Public Investments - Similarities and Differences from the Crowdfunding and Angel Perspective

    Here is the conversation with Tero Weckroth, Business Angel and Investment Expert from Finland about Public and Private Investments.

    Episode Links:
    Article to the Episode: https://lsg2g.substack.com/p/44-private-and-public-investments
    Video to the Episode: https://youtu.be/7WDHWOyaPQQ
    Tero Weckroth: https://www.linkedin.com/in/tero-weckroth-5b927/
    Chessboxing: https://www.nordicchessboxing.com/

    Podcast Links:
    Podcast Website: https://www.lifescienceget2gether.com/
    Community Partner: https://linktr.ee/lsg2g
    Christian Soschner: https://linktr.ee/soschner
    LSG2G Twitter: https://twitter.com/LGet2gether
    LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
    Podcast Episodes: https://pod.link/1493847125
    Episodes on YouTube:  https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV

    Timestamps:
    For those who want to listen to specific parts of the episode, here are the timestamps:

    (0:00) Opening words
    (0:30) Introduction Tero Weckroth
    (3:00) Life Science in Finland
    (8:30) Life Science Investments for Business Angels
    (22:00) Alzheimer Drug Development and Diagnostics – Biogen and Combinostics
    (26:40) What is the Right Pricing for Drugs on the Market?
    (30:00) Availability of Capital for Early-Stage Drug Development
    (33:00) Importance of a Team
    (38:00) Public Investments and Crowdfunding
    (44:00) Risk Management for Investors
    (46:00) Differences between Privat and Public Investment and Crowdfunding
    (49:30) Reddit – New Development on the Stock Market
    (01:00:00) New Macroeconomic Era?
    (01:06:00) Cash, Gold, or Digital Gold?
    (01:15:00) Technological Evolvement in the Investment Banking World
    (01:20:00) Effects of the Pandemic on Regulations
    (01:25:00) Cryptocurrencies - Bitcoin, Cardano, Etherum & co.
    Support the show (https://lsg2g.substack.com/subscribe?)

    • 1 hr 34 min
    #43: Tilmann Buerckstuemmer and Thomas Moser - Gene-Editing - The Next Game-Changing Technology?

    #43: Tilmann Buerckstuemmer and Thomas Moser - Gene-Editing - The Next Game-Changing Technology?

    Thomas Moser and Tilmann Buerckstuemmer lead the Austrian Life Science Company Aelian Biotechnology.

    Episode Links:
    Article to the Episode: https://lsg2g.substack.com/p/gene-editing-the-next-game-changing-d3f
    Video to the Episode: https://youtu.be/3bf7ChYUHLE
    Aelian Biotechnology: https://aelian.bio/
    Thomas Moser: https://www.linkedin.com/in/thomas-moser-79819a5/
    Tilmann Buerckstuemmer: https://www.linkedin.com/in/tilmann-burckstummer-19b65949/

    Podcast Links:
    Podcast Website: https://www.lifescienceget2gether.com/
    Community Partner: https://linktr.ee/lsg2g
    Christian Soschner: https://linktr.ee/soschner
    LSG2G Twitter: https://twitter.com/LGet2gether
    LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
    Podcast Episodes: https://pod.link/1493847125
    Episodes on YouTube:  https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV

    Timestamps:
    For those who want to listen to specific parts of the episode, here are the timestamps:
    (00:00) Introduction
    (02:23) Introduction Thomas Moser
    (05:45) Introduction Tilmann Bürckstümmer
    (08:40) Aelian Biotechnology
    (10:20) The Science Behind Aelian
    (17:50) Life Science Business Model
    (27:00) How to Setup Business Relationships in Life Science
    (34:35) Gene Editing - Why Did it Create Such a Hype?
    (41:00) History of Gene Editing with Insights Into CRISPR/Cas9
    (45:30) Vienna - Part of The CRISPR Community
    (47:50) IP of CRISPR
    (50:00) CRISPR - Real Life Use Cases
    (55:05) CRISPR in Cancer Research
    (59:20) Are Genetically Altered Human Beings Possible?
    (01:04:20) Genetically Enhanced Human Beings - Reality or SciFi?
    (01:08:00) Gene Editing and its Role in Agriculture
    (01:12:00) SARS-CoV-2 - What Role Did CRISPR Play in Fighting the Pandemic?
    (01:12:20) CRISPR Screen for SARS-CoV-2 - Technology of Aelian Biotechnology
    (01:15:00) Drug Discovery for SARS-CoV-2 with CRISPR
    (01:18:00) Fundraising for Life Science Companies
    (01:27:00) Comparison of the Investment Culture in Europe and the United States
    (01:31:00) Major Players in the CRISPR Field
    (01:32:00) CRISPR - IP Landscape
    (01:44:00) Final Question: Advice for First Time Entrepreneurs
    Support the show (https://lsg2g.substack.com/subscribe?)

    • 1 hr 47 min
    #42: Johannes Sarx and Philipp Hainzl - LISA - Life Science in Austria

    #42: Johannes Sarx and Philipp Hainzl - LISA - Life Science in Austria

    Have you ever wondered what role the small country Austria - located in the center of Europe - plays in Life Science?
    Then listen to the managing directors of LISAvienna, Johannes Sarx, and Philipp Hainzl. 
    LISAvienna is a joint life science platform operated by Austria Wirtschaftsservice and the Vienna Business Agency. On behalf of the Austrian Federal Ministry for Digital and Economic Affairs and the City of Vienna, it contributes to the advancement of life sciences in Vienna. 
    LISAvienna supports innovative biotech, pharmaceutical, medical device, and digital health companies in Vienna that develop and market new products, services, and processes. The platform links these companies with development partners and key customers. 
    As a central knowledge carrier, LISAvienna provides input for decisions to advance the life sciences in Vienna and contributes to positioning the city of Vienna as one of the leading European innovation centers.
    If you want to learn more about the Life Science Hot Spots in the center of Europe, then this episode is for you.

    In this talk we discussed the situation of Life Science in Austria and covered topics like
    Public FundingLife Science ConferencesInfrastructureAccess to global talent andprivate funding as well as the pharma industry.Join us for a colloquial chat over Life Science and Entrepreneurship.

    Conference in person in fall in Austria as discussed in the Episode:

    The European Forum for Industrial Biotechnology and the Bioeconomy (EFIB)will take place in #Vienna this year, and is themed “Delivering the EU Green Deal: Industrial biotechnology into business”. Join the dialogue on how biotech can enable a more circular and sustainable future. As EFIB’s local partner, LISAvienna is looking forward to connecting you to experts in the region. Mark your calendar for October 6-7, 2021 and join us at Austria Center Vienna - Internationales Kongresszentrum.

    This is a great opportunity to grow your network.

    Learn more about the regional expertise, potential partners and new products and services online. Many of these breakthrough innovations will be showcased at EFIB in Vienna.
    Image: acv.at / begehungen.de
    https://lnkd.in/euT5eRe
    Speaker:
    Christian Soschner
    Johannes Sarx
    Philipp Hainzl
    Organizations:
    CS Life Science Invest
    LISAvienna
    Support the show (https://lsg2g.substack.com/subscribe?)

    • 44 min
    #41: Christoph Lengauer - The 7 Key Success Factors of Building Great Life Science Companies.

    #41: Christoph Lengauer - The 7 Key Success Factors of Building Great Life Science Companies.

    This episode will discuss what it takes to build companies that develop novel therapies, vaccines, and diagnostics in the pharma industry.
    Since the pandemic, everybody got familiar with the key elements of pharma product development.
    But let’s take a closer look into the value chain of the industry.
    What does it really take to pick up a technology and bring it to patients?
    Questions we will discuss:
    Some questions we will focus on:
    What strategic approaches do exist for life science companies?How important is the team in developing a company to an IPO?Where can scientists find help when they want to start a company?About Christoph Lengauer (from Third Rock Ventures)
    “The most powerful thing about being a part of this industry is having the opportunity to improve the lives of patients and their families.”Christoph loves the ideation of new company concepts and focuses on the formation, development, and strategy of our portfolio companies. He is an accomplished scientist and drug hunter with the ability to translate that knowledge, insight, and expertise into compelling business strategies. Christoph has contributed to the discovery and development of eight FDA-approved medicines.
    Christoph is dedicated to making a dramatic difference in patients’ lives. He is enthusiastic about Third Rock’s approach to discover, launch and build great companies by focusing on bold ideas that meet at the intersection of science, strategy, business, and medicine. He is especially excited by initiatives at the firm focusing on the early detection of diseases in order to not only treat but cure patients.
    By leveraging his experiences and networks from academia, pharma, and biotech, he hopes to continue building great teams that help young companies succeed with this important mission.
    Over his career, Christoph has received numerous awards, including the Novartis Oncology’s President’s Award for Top Innovator, and has been elected to membership in the Johns Hopkins Society of Scholars.
    About Third Rock Ventures
    We discover, launch, and build great companies based on bold ideas that meet at the intersection of science, strategy, business, and medicine – where transformational science meets operational reality – providing the best opportunity to make a dramatic difference in patients’ lives.
    A FORMULA FOR INNOVATION
    We only invest in the best of those ideas. We are actively involved in the early stages of our companies’ development, typically serving as members of the founding management teams, to build a strong foundation, put in place the right people and culture, and set the companies on a path to scientific and operational excellence. We believe in the companies we launch and make big initial investments, often complemented by strategic alliances, to enable our companies to advance life-changing therapies, devices, and diagnostics. By creating value for patients, we create value for our investors.
    Link to the Video of the Recording:
    YouTube

    Speaker:
    Christoph Lengauer
    Christian Soschner
    Organizations:
    CS Life Science Invest
    Third Rock Ventures
    Support the show (https://lsg2g.substack.com/subscribe?)

    • 1 hr 5 min
    #40: beaconsmind - Max Weiland About Starting a Company and get it to a Dual Listing in only 6 years

    #40: beaconsmind - Max Weiland About Starting a Company and get it to a Dual Listing in only 6 years

    In history, most of the time, humans needed to provide everything they needed to make a living for themselves. Trading goods were part of life but didn’t take up most of the world’s population’s time.
    Industrialization changed the job profiles, the needs of workers, and the availability of goods.
    In this century, many people in the western world have jobs to provide services and get what they need for getting through the day in shops. Since I can think I mostly get my shopping done on Saturday.
    It is an event for the whole family, and often I invite friends for the coffee breaks to get a bit of socializing.
    In March 2020, the pandemic shifted a lot of commerce towards the internet and trained the western world's population to adopt online shopping.
    Whenever such a Black Swan Event happens, the consumer’s expectations shift as a result of such a dramatic experience.
    What new expectations will appear once the pandemic is over and consumers come back to real-life shopping more often?
    Max Weiland is working on solutions for such challenges with his team since 2014.
    About beaconsmind
    Founded in 2015 in Switzerland, beaconsmind is a pioneer in location-based marketing (LBM) software for retail chains. beaconsmind helps retailers run successful location-based marketing campaigns.
    By fitting stores with Bluetooth beacons that precisely locate and identify customers and integrating its Software Suite, beaconsmind opens a brand-new channel for retailers to interact with their customers, fundamentally transforming the shopping experience. Thanks to its solution, retailers can converge digital and physical shopping and address the convenience gaps.
    Consumers increasingly expect the convenience of the online shopping experience at the POS. In that regard, LBM is a proven tool and marketing channel for increasing POS sales productivity by implementing digital features to the in-store purchasing experience.
    While LBM is a largely fragmented and budding start-up scene, beaconsmind differentiates in many ways compared to relevant competitors:
    unique one-stop-shop featuring hardware and software;focus on retail with an actionable and plug-and-play solution;customized beacon solution requiring no maintenance;one of the first global roll-outs in an emerging industry with Adidas seeking to equip up to 15k POS worldwide with the beaconsmindsolution.The podcast guests and host will discuss questions like?
    Foundation of a novel companyKey Milestones in beaconsmind corporate developmentBenefits of an IPO in Europebeaconsmind solutionsThe future of CommerceInterested?
    Link to the Video of the Recording:
    YouTube

    Speaker:
    Christian Soschner
    Max Weiland
    Organizations:
    CS Life Science Invest
    beaconsmind
    Support the show (https://lsg2g.substack.com/subscribe?)

    • 1 hr 11 min
    #39: All You Need to Know About the Novel €95.5 Billion Horizon Europe Programme...

    #39: All You Need to Know About the Novel €95.5 Billion Horizon Europe Programme...

    This podcast episode will discuss the EU’s next framework program for research and innovation, Horizon Europe, and the exciting opportunities this program offers businesses, scientists, and investors. With the launch of the Horizon Europe program just weeks away, we will share insight into the program's novelties, where to start, and tips on how to be successful. 
    The Podcast Host, guests Kimberly Cornfield and Michael Browne will discuss questions like:
    What is new in Horizon Europe? The European Innovation Council, Missions and Clusters – all you need to knowFunding for DeepTech? The opportunities for high-risk/high gain and interdisciplinary research and innovation collaborationWhere, when, and how to apply for Horizon Europe funding? – tips from the expertsWe shall address all these questions and discuss the latest priorities in EU research and innovation funding and the importance of collaboration.
    Our guests in this episode:
    Kimberly Cornfield is Head of European Research and Innovation at University College London (UCL), one of the top-performing universities under the EU’s Horizon 2020 program, having secured ca. €400 million over the last seven years to support its research and innovation activities. To support UCL in upholding its place as one of the leading universities in the next EU research and innovation program, Horizon Europe, and achieving its impact objectives, Kimberly and her team connect scientists and business around EU collaborative funding opportunities and offer a suite of support services to improve the chances of success in obtaining funding and achieving their impact objectives.
    Michael Browne is Director and Co-founder at Crowdhelix - an Open Innovation Platform that forges links between an international network of excellent researchers and innovating companies to help deliver pioneering collaborative projects. Michael has worked in the European Research & Innovation space for more than 15 years and is a recognized expert in Framework Programme funding.

    Host:
    Christian Soschner
    Link to the Video of the Recording:
    Youtube Video

    Be part of our Network:
    Subscribe here:  Link
    Support the show (https://lsg2g.substack.com/subscribe?)

    • 1 hr 4 min

Top Podcasts In Business